narrative_review·obstetrics and gynecology, oncology, infectious disease, immunology·PMC10378257
Herpes Simplex Virus, Human Papillomavirus, and Cervical Cancer: Overview, Relationship, and Treatment Implications
Cancers · 5 authors, 3 centres
AI SUMMARY
FIDELITY 100%
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This narrative review evaluates the established role of HPV in cervical cancer pathogenesis and examines the controversial and unproven potential involvement of HSV-2. The central finding is that while HPV/HSV-2 coinfection has been associated with higher cervical cancer risk in some studies, a definitive causal link between HSV and cervical cancer has not been established.
Full summary
709 CHARS
The authors describe well-characterized HPV oncogenic proteins E5, E6, and E7 as key drivers of cervical carcinogenesis, while noting that the role of HSV, particularly HSV-2, remains controversial with mixed results across studies. Some evidence suggests HPV/HSV-2 coinfection may elevate cervical cancer risk, and the authors discuss the 'hit and run' hypothesis as a possible mechanism by which HSV could initiate but not sustain oncogenesis. However, the review concludes that an association between HSV-2 and cervical cancer has not been unambiguously established, and even if one existed, confounding by shared immunological compromise, genetic predisposition, or lifestyle factors could account for it.